Galapagos NV - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
GLPG Nasdaq 2836 www.glpg.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Galapagos NV

Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts - Apr 23rd, 2025 8:01 pm
Galapagos Announces Executive Leadership Updates - Apr 21st, 2025 8:10 pm
Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025 - Apr 15th, 2025 5:30 am
Is Galapagos (GLPG) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? - Apr 11th, 2025 7:05 pm
Biotech stocks slide as Marks resignation seen being negative for sector - Apr 1st, 2025 3:50 pm
Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders’ Meeting - Mar 27th, 2025 8:01 pm
Galapagos to Present at Upcoming Investor Conferences - Feb 24th, 2025 9:01 pm
Galapagos (AMS:GLPG) adds €185m to market cap in the past 7 days, though investors from five years ago are still down 89% - Feb 18th, 2025 8:22 am
Galapagos receives transparency notification and 13D filing from Tang Capital - Feb 17th, 2025 9:01 pm
Galapagos NV (GLPG) (FY 2024) Earnings Call Highlights: Strategic Shifts and Financial Resilience - Feb 14th, 2025 7:09 am
Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update - Feb 12th, 2025 9:01 pm
Galapagos NV (GLPG): A Cheap Biotech Stock to Invest In Now - Feb 12th, 2025 1:03 pm
Galapagos (GLPG) Loses -21.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Feb 5th, 2025 2:35 pm
Galapagos Plans to Split Into Two Entities, Revise Agreement With Gilead Sciences, Reduce Workforce by 40% - Jan 8th, 2025 12:16 pm
Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities - Jan 8th, 2025 6:30 am
Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Jan 7th, 2025 9:01 pm
Galapagos NV (AMS:GLPG) stock most popular amongst retail investors who own 56%, while public companies hold 25% - Dec 13th, 2024 6:16 am
ASH 2024: Galapagos presents positive results for a seven-day ‘vein-to-vein’ CAR T-cell therapy - Dec 11th, 2024 4:00 am
Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma - Dec 7th, 2024 5:30 pm
Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024 - Nov 5th, 2024 9:01 pm